Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adj...
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment
About this item
Full title
Author / Creator
Puglisi, Soraya , Calabrese, Anna , Basile, Vittoria , Ceccato, Filippo , Scaroni, Carla , Simeoli, Chiara , Torlontano, Massimo , Cannavò, Salvatore , Arnaldi, Giorgio , Stigliano, Antonio , Malandrino, Pasqualino , Saba, Laura , Altieri, Barbara , Della Casa, Silvia , Perotti, Paola , Berchialla, Paola , De Filpo, Giuseppina , Canu, Letizia , Loli, Paola , Reimondo, Giuseppe and Terzolo, Massimo
Publisher
Switzerland: MDPI
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI
More information
Scope and Contents
Contents
Mitotane is used as a post-operative adjuvant treatment for patients with adrenocortical carcinoma. Monitoring of plasma mitotane concentrations is recommended, but we do not know what impact target concentrations have on patient outcome. To answer this question, we retrospectively analyzed patient records in the Lysosafe Online
database (HRA Ph...
Alternative Titles
Full title
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment
Authors, Artists and Contributors
Author / Creator
Calabrese, Anna
Basile, Vittoria
Ceccato, Filippo
Scaroni, Carla
Simeoli, Chiara
Torlontano, Massimo
Cannavò, Salvatore
Arnaldi, Giorgio
Stigliano, Antonio
Malandrino, Pasqualino
Saba, Laura
Altieri, Barbara
Della Casa, Silvia
Perotti, Paola
Berchialla, Paola
De Filpo, Giuseppina
Canu, Letizia
Loli, Paola
Reimondo, Giuseppe
Terzolo, Massimo
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6912753
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6912753
Other Identifiers
ISSN
2077-0383
E-ISSN
2077-0383
DOI
10.3390/jcm8111850
